ERBB2 and breast cancer: Invasive BC is classified into four distinct subtypes based on the expression of estrogen receptor alpha (ERα), progesterone receptor (PR), human epidermal growth factor receptor 2 (HER2), and Ki-67 (Inic et al., 2014; Harbeck et al., 2019).